107 related articles for article (PubMed ID: 18349273)
1. UGT1A1 genetic polymorphisms, endogenous estrogen exposure, soy food intake, and endometrial cancer risk.
Deming SL; Zheng W; Xu WH; Cai Q; Ruan Z; Xiang YB; Shu XO
Cancer Epidemiol Biomarkers Prev; 2008 Mar; 17(3):563-70. PubMed ID: 18349273
[TBL] [Abstract][Full Text] [Related]
2. Association of endometrial cancer risk with a functional polymorphism (Asp(327)Asn) in the sex hormone-binding globulin gene.
Kataoka N; Cai Q; Xu WH; Xiang YB; Cai H; Zheng W; Shu XO
Cancer; 2007 Apr; 109(7):1296-302. PubMed ID: 17315164
[TBL] [Abstract][Full Text] [Related]
3. Genetic polymorphisms in uridine diphospho-glucuronosyltransferase 1A1 (UGT1A1) and risk of breast cancer.
Adegoke OJ; Shu XO; Gao YT; Cai Q; Breyer J; Smith J; Zheng W
Breast Cancer Res Treat; 2004 Jun; 85(3):239-45. PubMed ID: 15111762
[TBL] [Abstract][Full Text] [Related]
4. Interaction of soy food and tea consumption with CYP19A1 genetic polymorphisms in the development of endometrial cancer.
Xu WH; Dai Q; Xiang YB; Long JR; Ruan ZX; Cheng JR; Zheng W; Shu XO
Am J Epidemiol; 2007 Dec; 166(12):1420-30. PubMed ID: 17827443
[TBL] [Abstract][Full Text] [Related]
5. Cytochrome P450 1B1 and catechol-O-methyltransferase polymorphisms and endometrial cancer susceptibility.
McGrath M; Hankinson SE; Arbeitman L; Colditz GA; Hunter DJ; De Vivo I
Carcinogenesis; 2004 Apr; 25(4):559-65. PubMed ID: 14656940
[TBL] [Abstract][Full Text] [Related]
6. Cytochrome P450 1B1 gene polymorphisms and postmenopausal endometrial cancer risk.
Rylander-Rudqvist T; Wedrén S; Jonasdottir G; Ahlberg S; Weiderpass E; Persson I; Ingelman-Sundberg M
Cancer Epidemiol Biomarkers Prev; 2004 Sep; 13(9):1515-20. PubMed ID: 15342454
[TBL] [Abstract][Full Text] [Related]
7. Interaction of soy and 17beta-HSD1 gene polymorphisms in the risk of endometrial cancer.
Dai Q; Xu WH; Long JR; Courtney R; Xiang YB; Cai Q; Cheng J; Zheng W; Shu XO
Pharmacogenet Genomics; 2007 Feb; 17(2):161-7. PubMed ID: 17301695
[TBL] [Abstract][Full Text] [Related]
8. Estrogen sulfation genes, hormone replacement therapy, and endometrial cancer risk.
Rebbeck TR; Troxel AB; Wang Y; Walker AH; Panossian S; Gallagher S; Shatalova EG; Blanchard R; Bunin G; DeMichele A; Rubin SC; Baumgarten M; Berlin M; Schinnar R; Berlin JA; Strom BL
J Natl Cancer Inst; 2006 Sep; 98(18):1311-20. PubMed ID: 16985250
[TBL] [Abstract][Full Text] [Related]
9. Estrogen receptor beta (ESR2 ) polymorphisms and endometrial cancer (United States).
Setiawan VW; Hankinson SE; Colditz GA; Hunter DJ; De Vivo I
Cancer Causes Control; 2004 Aug; 15(6):627-33. PubMed ID: 15280642
[TBL] [Abstract][Full Text] [Related]
10. Sulfotransferase 1A1 polymorphism, endogenous estrogen exposure, well-done meat intake, and breast cancer risk.
Zheng W; Xie D; Cerhan JR; Sellers TA; Wen W; Folsom AR
Cancer Epidemiol Biomarkers Prev; 2001 Feb; 10(2):89-94. PubMed ID: 11219777
[TBL] [Abstract][Full Text] [Related]
11. The influence of the Cyclin D1 870 G>A polymorphism as an endometrial cancer risk factor.
Ashton KA; Proietto A; Otton G; Symonds I; McEvoy M; Attia J; Gilbert M; Hamann U; Scott RJ
BMC Cancer; 2008 Sep; 8():272. PubMed ID: 18822177
[TBL] [Abstract][Full Text] [Related]
12. Genetic factors in catechol estrogen metabolism in relation to the risk of endometrial cancer.
Doherty JA; Weiss NS; Freeman RJ; Dightman DA; Thornton PJ; Houck JR; Voigt LF; Rossing MA; Schwartz SM; Chen C
Cancer Epidemiol Biomarkers Prev; 2005 Feb; 14(2):357-66. PubMed ID: 15734958
[TBL] [Abstract][Full Text] [Related]
13. Polymorphisms in O6-methylguanine DNA methyltransferase and endometrial cancer risk.
Han J; Hankinson SE; De Vivo I
Carcinogenesis; 2006 Nov; 27(11):2281-5. PubMed ID: 16777993
[TBL] [Abstract][Full Text] [Related]
14. Estrogen replacement therapy and endometrial cancer risk: unresolved issues. The Endometrial Cancer Collaborative Group.
Brinton LA; Hoover RN
Obstet Gynecol; 1993 Feb; 81(2):265-71. PubMed ID: 8380913
[TBL] [Abstract][Full Text] [Related]
15. Association of genetic polymorphisms in UGT1A1 with breast cancer and plasma hormone levels.
Guillemette C; De Vivo I; Hankinson SE; Haiman CA; Spiegelman D; Housman DE; Hunter DJ
Cancer Epidemiol Biomarkers Prev; 2001 Jun; 10(6):711-4. PubMed ID: 11401924
[TBL] [Abstract][Full Text] [Related]
16. Estrogen receptor polymorphisms and the risk of endometrial cancer.
Ashton KA; Proietto A; Otton G; Symonds I; McEvoy M; Attia J; Gilbert M; Hamann U; Scott RJ
BJOG; 2009 Jul; 116(8):1053-61. PubMed ID: 19438492
[TBL] [Abstract][Full Text] [Related]
17. A population-based case-control study of the Arg399Gln polymorphism in DNA repair gene XRCC1 and risk of breast cancer.
Shu XO; Cai Q; Gao YT; Wen W; Jin F; Zheng W
Cancer Epidemiol Biomarkers Prev; 2003 Dec; 12(12):1462-7. PubMed ID: 14693738
[TBL] [Abstract][Full Text] [Related]
18. Interindividual variation in nucleotide excision repair genes and risk of endometrial cancer.
Weiss JM; Weiss NS; Ulrich CM; Doherty JA; Voigt LF; Chen C
Cancer Epidemiol Biomarkers Prev; 2005 Nov; 14(11 Pt 1):2524-30. PubMed ID: 16284373
[TBL] [Abstract][Full Text] [Related]
19. Genetic polymorphisms in human SULT1A1 and UGT1A1 genes associate with breast tumor characteristics: a case-series study.
Shatalova EG; Walther SE; Favorova OO; Rebbeck TR; Blanchard RL
Breast Cancer Res; 2005; 7(6):R909-21. PubMed ID: 16280036
[TBL] [Abstract][Full Text] [Related]
20. Synergistic effects of STK15 gene polymorphisms and endogenous estrogen exposure in the risk of breast cancer.
Dai Q; Cai QY; Shu XO; Ewart-Toland A; Wen WQ; Balmain A; Gao YT; Zheng W
Cancer Epidemiol Biomarkers Prev; 2004 Dec; 13(12):2065-70. PubMed ID: 15598762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
